9.1.2 Drugs used in megaloblastic anaemias

Megaloblastic anaemia is usually due to Vitamin B₁₂ or folate deficiency; the specific deficiency and underlying cause must be identified. Treatment is usually only started once a firm diagnosis is made. Where there is neurological involvement, seek urgent specialist advice from a haematologist. In emergencies, where delayed treatment may be dangerous, both folate and Vitamin B₁₂ may be required initially, until assay results are known. Folate must not be used alone in undiagnosed megaloblastic anaemia due to the risk of B₁₂ deficiency leading to peripheral neuropathy.

 For further information refer to NICE CKS Anaemia – B12 and folate deficiency

Vitamin B12 deficiency

Prescribing Notes

• For further information on diagnosis and management of Vitamin B₁₂ deficiency see NICE guideline (NG239)
• Non- diet related Vitamin B₁₂ deficiencies are attributable to malabsorption, therefore there is little place for the use of low-dose oral Vitamin B₁₂ in non-diet related vitamin B₁₂ deficiency
• There is no justification for prescribing multiple ingredient vitamin preparations containing  Vitamin B₁₂ or folic acid
• The medicines used to treat Vitamin B₁₂ deficiency (hydroxocobalamin, cyanocobalamin) contain cobalt; advise patients with known cobalt allergy to be vigilant for sensitivity reactions, see MHRA for further details

Folate deficiency

Prescribing Notes

• Folic acid has few indications for long-term therapy since most causes of folate deficiency are self-limiting or will yield to a short course of treatment.
• Do not use in undiagnosed megaloblastic anaemia unless vitamin B₁₂ is administered concurrently otherwise neuropathy may be precipitated.
• For prophylaxis in pregnancy, see Supplementations in Pregnancy below
• Where folic acid is prescribed to reduce methotrexate toxicity, the 5mg tablet should be used, not 400microgram. The usual dose is folic acid 5mg weekly, one to two days after methotrexate.

Supplementations in Pregnancy / Pre-conception

Prescribing notes

Folic acid supplements taken before and during pregnancy can reduce the occurrence of neural tube defects. The risk of a neural tube defect occurring in a child should be assessed and folic acid given as follows:

• Women at a low risk of conceiving a child with a neural tube defect(NTD) should be advised to take folic acid as a medicinal or food supplement at a dose of 400 micrograms daily before conception and until week 12 of pregnancy. Women who have not been taking folic acid and who suspect they are pregnant should start at once and continue until week 12 of pregnancy.
• Women at high risk* of neural tube defects who wish to become pregnant (or who are at risk of becoming pregnant) should be advised to take folic acid 5mg daily and continue until week 12 of pregnancy. Women with sickle-cell disease, thalassaemia or thalassaemia trait should take folic acid 5mg throughout pregnancy.

*High risk may include if:

• • Either partner has an NTD, they have had a previous pregnancy affected by an NTD, or they have a family history of an NTD.
  • The woman is taking anti–epileptic medication or certain anti-retroviral medication for HIV
  • The woman has diabetes mellitus, sickle cell anaemia, or thalassaemia.
  • The woman is obese (BMI of 30 and above)